BSEBoard Meeting2d ago · 29 Oct 2026, 05:08 pm
Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve 1. To consider and approve the proposed objects and utilisation of proceeds of the Rights Issue, including the proposed deployment of funds towards the objects set out in the Draft Letter of Offer. 2. To consider and approve the Draft Letter of Offer ('DLOF') in connection with the proposed ....
Arvaya Healthcare Ltd · 524723
✦ AI SummaryFundraise
Arvaya Healthcare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 04/11/2026 to consider and approve the proposed objects and utilisation of proceeds of the Rights Issue, Draft Letter of Offer, and material related party transactions.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact7/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Arvaya Healthcare Ltd - 524723 - Board Meeting Intimation for Prior Intimation Of The Board Meeting Pursuant To Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Attachments (1)
📄pdf
Download →
e208776a-a711-4cab-830a-de3610aafd33.pdf
View document text
Date: 29.10.2026
The Secretary,
Listing Department
Bombay Stock Exchange Ltd
Phiroze Jeejeebhoy Towers,
Street, Mumbai – 400 001
Scrip Code: 524723
Reference: ISIN: INE491D01017
Subject: Prior intimation of the Board Meeting pursuant to Regulation 29 of the Securities
and Exchange Board of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015.
Respected Authorities,
Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, as amended ("SEBI Listing Regulations"), we wish
to inform that a Meeting of the Board of Directors of the Company is scheduled to be held on
Wednesday, November 4, 2026 to inter-alia, consider and approve:
1. To consider and approve the proposed objects and utilisation of proceeds of the Rights Issue,
including the proposed deployment of funds towards the objects set out in the Draft Letter of
Offer.
2. To consider and approve the Draft Letter of Offer (“DLOF”) in connection with the proposed
Rights Issue and to authorise the necessary filings and submissions with the BSE Limited and
other regulatory authorities, as applicable.
3. To consider and approve the proposed material related party transactions with various related
parties of the Company subject to the recommendations of the Audit Committee and approval of
the shareholders, wherever applicable, in accordance with the provisions of the Companies Act,
2013, the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
We request you to kindly take the same on your record and oblige.
Thanking you.
Yours faithfully,
FOR AND ON BEHALF OF
ARVAYA HEALTHCARE LIMITED
(Formerly known as Bijoy Hans Limited)
Kaushal Shah
Managing Director
DIN: 02175130
Date: 29th October 2026
Place: Pune